Diabetic retinopathy and other ocular findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study

Diabetes Care

Volumn 37, Issue 1, 2014, Pages 17-23

  Aiello, Lloyd Paul ^a  

^a JOSLIN DIABETES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN;

ADOLESCENT; ADULT; ARTICLE; BLOOD GLUCOSE MONITORING; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DIABETIC RETINOPATHY; DISEASE CLASSIFICATION; DISEASE CONTROL; DISEASE COURSE; DISEASE SEVERITY; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; INTENSIVE CARE; LOW LEVEL LASER THERAPY; MAJOR CLINICAL STUDY; MICROANGIOPATHY; NONPROLIFERATIVE DIABETIC RETINOPATHY; OBSERVATIONAL STUDY; ONSET AGE; PRIMARY PREVENTION; RETINA MACULA EDEMA; RISK REDUCTION; SECONDARY PREVENTION; SELF MONITORING; TREATMENT DURATION; AGED; BLOOD; CLINICAL TRIAL (TOPIC); COMPLICATION; DIABETES MELLITUS, TYPE 1; DOSE RESPONSE; FEMALE; MALE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; RETINA; RISK FACTOR; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BLOOD GLUCOSE; CLINICAL TRIALS AS TOPIC; DIABETES MELLITUS, TYPE 1; DIABETIC RETINOPATHY; DISEASE PROGRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INCIDENCE; INSULIN; MALE; MIDDLE AGED; RETINA; RISK FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84892422524     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc13-2251     Document Type: Article

References (15)

1. Joslin EP. The Treatment of Diabetes Mellitus. Philadelphia, PA, and New York,NY, Lea and Febiger, 1916
2. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.N Engl J Med 1993;329:977-986
3. The DCCT Research Group. The Diabetes Control and Complications Trial (DCCT).Design and methodologic considerations for the feasibility phase. Diabetes 1986;35:530-545
4. Nathan DM. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study at 30 years: Overview. Diabetes Care 2014;37:9-16
5. Early Treatment Diabetic Retinopathy Study Research Group. Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Ophthalmology 1991;98(Suppl):823-833
6. Early Treatment Diabetic Retinopathy Study Research Group. Grading diabetic retinopathy from stereoscopic color fundus photographsdan extension of the modified Airlie House classification. ETDRS report number 10. Ophthalmology 1991;98(Suppl):786-806
7. The Diabetes Control and Complications Trial Research Group. Color photography vs fluorescein angiography in the detection of diabetic retinopathy in the diabetes control and complications trial. Arch Ophthalmol 1987;105:1344-1351
8. White NH, Sun W, Cleary PA, et al.; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group.Prolonged effect of intensive therapy on the risk of retinopathy complications in patients with type 1 diabetes mellitus: 10 years after the Diabetes Control and Complications Trial. Arch Ophthalmol 2008; 126:1707-1715
9. Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group.Epidemiology of Diabetes Interventions and Complications (EDIC): Design,implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort.Diabetes Care 1999;22:99-111
10. Diabetes Control and Complications Trial Research Group. The effect of intensive diabetes therapy on the progression of diabetic retinopathy in insulin-dependent diabetes mellitus: The Diabetes Control and Complications Trial. Arch Ophthalmol 1995;113:36-51
11. The Diabetes Control and Complications Trial Research Group. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial. Diabetes 1995;44:968-983
12. Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA 2002;287:2563-2569
13. Diabetes Control and Complications Trial Research Group. Early worsening of diabetic retinopathy in the Diabetes Control and Complications Trial. Arch Ophthalmol 1998;116:874-886
14. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N Engl J Med 2000;342:381-389
15. Nathan DM, Zinman B, Cleary PA, et al.; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Research Group.Modern-day clinical course of type 1 diabetes mellitus after 30 years duration:the Diabetes Control and Complications Trial/Epidemiology of DiabetesInterventions and Complications and Pittsburgh Epidemiology of Diabetes Complications experience (1983-2005). Arch Intern Med 2009;169:1307-1316 Kidney Diseases Kidney Diseases